SCRN flashcards
SCRN · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Ischemic penumbra
- Brain tissue with reduced blood flow that is electrically silent but metabolically viable; it can be salvaged if reperfusion is restored quickly enough.
- MCA occlusion syndrome
- Contralateral face and arm weakness worse than leg weakness, gaze deviation toward the lesion, and aphasia if the dominant hemisphere is involved; neglect if nondominant.
- ACA infarction signs
- Contralateral leg weakness greater than arm weakness, abulia, urinary incontinence, and grasp reflex, caused by occlusion of the anterior cerebral artery.
- Lacunar infarct
- Small deep infarct from occlusion of a penetrating artery, producing pure motor, pure sensory, sensorimotor, or ataxic hemiparesis without cortical signs.
- Cerebral autoregulation range
- Cerebral blood flow stays near 50 mL/100 g/min while mean arterial pressure ranges from about 60 to 150 mm Hg; the curve is right-shifted in chronic hypertension.
- Basilar artery occlusion
- Produces quadriparesis, cranial nerve palsies, gaze abnormalities, and fluctuating consciousness; it may progress to locked-in syndrome or coma with high mortality.
- NIHSS score range
- A 15-item scale scored 0 to 42; higher scores mean more severe deficits, and scores of 21 or more generally indicate severe stroke.
- Noncontrast CT first step
- Rapidly excludes intracranial hemorrhage before thrombolysis; early ischemic changes such as hyperdense MCA sign and loss of the insular ribbon may be subtle.
- ASPECTS score
- A 10-point CT scoring system for MCA territory ischemia; each affected region loses one point, and scores of 6 or more generally favor thrombectomy.
- DWI-FLAIR mismatch
- An acute ischemic lesion visible on diffusion-weighted imaging without FLAIR signal suggests onset within about 4.5 hours, which is useful in wake-up stroke.
- Stroke mimics
- Conditions resembling stroke, including hypoglycemia, seizure with postictal deficit, migraine aura, conversion disorder, sepsis, and brain tumor; glucose testing is essential.
- Alteplase dosing
- 0.9 mg/kg intravenously to a maximum of 90 mg; give 10 percent as a one-minute bolus and infuse the remainder over 60 minutes within 4.5 hours.
- Blood pressure before thrombolysis
- Blood pressure must be below 185/110 mm Hg before intravenous alteplase and kept below 180/105 mm Hg for the first 24 hours after treatment.
- Thrombectomy criteria
- Large vessel occlusion of the internal carotid or MCA M1 with NIHSS 6 or more, ASPECTS 6 or more, and treatment up to 24 hours with favorable perfusion imaging.
- Door-to-needle time
- The interval from hospital arrival to the intravenous thrombolytic bolus; the target is 60 minutes or less, since faster treatment preserves more brain tissue.
- ICH blood pressure target
- For intracerebral hemorrhage presenting with systolic pressure of 150 to 220 mm Hg, lower systolic smoothly to about 140 mm Hg promptly.
- Post-thrombolysis antithrombotic timing
- Delay antiplatelet and anticoagulant drugs for 24 hours after thrombolysis and obtain follow-up imaging to exclude hemorrhagic transformation first.
- Dysphagia screening
- Screen swallowing before any oral intake, medication, or food; dysphagia affects roughly half of stroke patients and raises aspiration pneumonia risk.
- Modified Rankin Scale
- A 0 to 6 disability scale; scores of 0 to 2 indicate functional independence and are the usual favorable outcome measure in stroke trials.
- Constraint-induced movement therapy
- Restrains the unaffected upper limb while intensively training the affected arm in patients who retain some voluntary wrist and finger movement.
- Spasticity assessment
- Graded with the modified Ashworth scale; managed with positioning, stretching, therapy, and focal botulinum toxin injections when spasticity is disabling.
- Interdisciplinary rehabilitation team
- Includes physiatry, physical therapy, occupational therapy, speech-language pathology, nursing, social work, and neuropsychology, working toward shared functional goals.
- Dual antiplatelet therapy after TIA
- Aspirin plus clopidogrel started within 24 hours for minor ischemic stroke or high-risk TIA, continued for 21 to 90 days, then reduced to single antiplatelet therapy.
- Anticoagulation for atrial fibrillation
- Direct oral anticoagulants are preferred over warfarin for nonvalvular atrial fibrillation; warfarin remains standard for mechanical valves and moderate-to-severe mitral stenosis.
- Carotid endarterectomy timing
- For symptomatic 70 to 99 percent carotid stenosis, surgery is most beneficial within two weeks of the index event and should be done by a low-complication surgeon.
- High-intensity statin after stroke
- Atorvastatin 80 mg or rosuvastatin 20 to 40 mg regardless of baseline LDL, aiming for an LDL cholesterol level below 70 mg/dL.
- PFO closure indication
- Considered for cryptogenic ischemic stroke in patients younger than 60 with a patent foramen ovale and high-risk anatomic features, after other causes are excluded.
- Emergency consent exception
- When a patient lacks capacity and no surrogate is available, thrombolysis may proceed under presumed consent because delay would cause harm.
- Post-stroke depression screening
- Depression affects about one third of survivors; screen with the PHQ-9 or a similar tool during acute and follow-up visits and treat with therapy or antidepressants.
- Caregiver burden
- Family caregivers face depression, financial strain, and physical strain; respite services, training, and support groups reduce burden and improve patient outcomes.
- Inpatient rehabilitation facility criteria
- Requires tolerance of three hours of therapy daily, need for at least two therapy disciplines, and a realistic expectation of functional improvement.
- Goals-of-care discussion
- Documents patient values and preferences with family and the team, guiding escalation of treatment, resuscitation status, and withdrawal decisions in severe stroke.